Heart Sisters
MARCH 3, 2024
The more heart patients learn about heart disease, the better we can manage the 8,765 hours per year we aren't spending with our cardiologist. Here's how 'Cardiac College for Women' can help us manage those hours.
Cardiovascular Ultrasound
MARCH 3, 2024
Heart failure with preserved ejection fraction (HFpEF) represents a significant proportion of heart failure cases. Accurate diagnosis is challenging due to the heterogeneous nature of the disease and limitatio.
Frontiers in Cardiovascular Medicine
MARCH 3, 2024
Background Objective tools to define the optimal time for referral for advanced therapies and to help guide escalation and de-escalation of support can improve management decisions and outcomes for patients with advanced heart failure. The current parameters have variable prognostic potential depending on the patient population being studied and often have arbitrary thresholds.
Nature Reviews - Cardiology
MARCH 3, 2024
Nature Reviews Cardiology, Published online: 04 March 2024; doi:10.1038/s41569-024-01005-1 A metabolic product of excess niacin promotes vascular inflammation in preclinical models and is associated with increased rates of major adverse cardiovascular events in humans.
Frontiers in Cardiovascular Medicine
MARCH 3, 2024
Background Covert atrial fibrillation (AF) is a predominant aetiology of embolic stroke of undetermined source (ESUS). Evidence suggested that AF is more frequently detected by implantable loop recorder (ILR) than by conventional monitoring. However, the predictive factors associated with occult AF detected using ILRs are not well established yet. In this study we aim to investigate the predictors of AF detection in patients with ESUS undergoing an ILR.
HCPLive
MARCH 3, 2024
Our February 2024 ophthalmology month-in-review features an in-depth look into global vision loss rates, a new clinical quiz on AAO guidelines, and two episodes of our flagship ophthalmology podcast, New Insight with Veeral Sheth, MD.
Frontiers in Cardiovascular Medicine
MARCH 3, 2024
Introduction More than 76,000 women die yearly from preeclampsia and hypertensive disorders of pregnancy. Early diagnosis and management of preeclampsia can improve outcomes for both mother and baby. In this study, we developed artificial intelligence models to detect and predict preeclampsia from electrocardiograms (ECGs) in point-of-care settings.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Frontiers in Cardiovascular Medicine
MARCH 3, 2024
Valvular heart disease is a global health burden with substantial mortality. The left-sided valvular diseases have been extensively described using the robust treatment strategies available. By contrast, the right-sided diseases, particularly the tricuspid valve (TV) and associated regurgitation, still have much to be delineated. Worsening tricuspid regurgitation (TR) is associated with increased mortality; the non-invasive management is suboptimal; and surgical approaches carry significant risk
Circulation
MARCH 3, 2024
Circulation, Volume 149, Issue 10 , Page 729-731, March 5, 2024.
Frontiers in Cardiovascular Medicine
MARCH 3, 2024
Introduction Heart failure with preserved ejection fraction (HFpEF) is a complex disease process influenced by metabolic disorders, systemic inflammation, myocardial fibrosis, and microvascular dysfunction. The goal of our study is to identify potential relationships between plasma biomarkers and cardiac magnetic resonance (CMR) imaging markers in patients with HFpEF.
Journal of Cardiovascular Electrophysiology
MARCH 3, 2024
Abstract Introduction Cardiac contractility modulation (CCM) is a medical device-based therapy delivering non-excitatory electrical stimulations to the heart to enhance cardiac function in heart failure (HF) patients. The lack of human in vitro tools to assess CCM hinders our understanding of CCM mechanisms of action. Here, we introduce a novel chronic (i.e., 2-day) in vitro CCM assay to evaluate the effects of CCM in a human 3D microphysiological system consisting of engineered cardiac tissues
Frontiers in Cardiovascular Medicine
MARCH 3, 2024
Background Preeclampsia (PE) is associated with subsequent higher risk of cardiovascular and kidney disease. Serum copeptin, as a proxy for vasopressin, and urinary uromodulin, were associated with PE physiopathology and kidney functional mass respectively. We describe concentrations of these proteins in the post-partum period and characterize their association with persistent hypertension (HTN) or albuminuria.
Journal of Cardiovascular Electrophysiology
MARCH 3, 2024
Abstract Introduction Through systematic scientific rigor, the CLOSE guided workflow was developed and has been shown to improve pulmonary vein isolation durability. However, this technique was developed at a time when using power-controlled ablation catheters with conventional power ranges was the norm. There has been increased adoption of a high-power and very high-power short-duration ablation practice propelled by the availability of the temperature-controlled radiofrequency QDOT MICRO cathe
Frontiers in Cardiovascular Medicine
MARCH 3, 2024
Introduction The presence of abdominal aortic calcification (AAC) is strongly linked to the development of atherosclerosis and the incidence of morbidity and mortality related to cardiovascular diseases (CVD). Urinary albumin creatinine ratio (UACR) was found related with the increased risk of CVD. The aim of this study is to explore the relationship between the UACR and severe AAC (SAAC).
Journal of Cardiovascular Electrophysiology
MARCH 3, 2024
Complete left bundle branch block (CLBBB)-like QRS morphology of right ventricular pacing at pacemaker implantation satisfying the American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society criteria of CLBBB was associated with development of pacing induced cardiomyopathy. Abstract Introduction Right ventricular (RV) pacing sometimes causes left ventricular (LV) systolic dysfunction, also known as pacing-induced cardiomyopathy (PICM).
Frontiers in Cardiovascular Medicine
MARCH 3, 2024
Background Early ventricular tachycardia/fibrillation (VT/VF) in patients with ST-elevation myocardial infarction (STEMI) has higher morbidity and mortality. This study examines gender-differentiated risk factors and underlying mechanisms for early onset VT/VF in STEMI. Methods We analyzed data from 2,964 consecutive STEMI patients between January 1, 2008 and December 31, 2021.
The American Journal of Cardiology
MARCH 3, 2024
Publication date: Available online 2 March 2024 Source: The American Journal of Cardiology Author(s): Leonard Ilkhanoff, Brett Atwater, Ana Barac
Circulation
MARCH 3, 2024
Circulation, Volume 149, Issue 10 , Page e954-e954, March 5, 2024.
Coronary Artery Disease Journal
MARCH 3, 2024
No abstract available
Circulation
MARCH 3, 2024
Circulation, Volume 149, Issue 10 , Page e953-e953, March 5, 2024.
Frontiers in Cardiovascular Medicine
MARCH 3, 2024
Introduction Despite ongoing efforts to minimize sex bias in diagnosis and treatment of acute coronary syndrome (ACS), data still shows outcomes differences between sexes including higher risk of all-cause mortality rate among females. Hence, the aim of the current study was to examine sex differences in ACS in-hospital mortality, and to implement artificial intelligence (AI) models for prediction of in-hospital mortality among females with ACS.
Circulation
MARCH 3, 2024
Circulation, Volume 149, Issue 10 , Page e955-e955, March 5, 2024.
Circulation
MARCH 3, 2024
Circulation, Volume 149, Issue 10 , Page 760-763, March 5, 2024.
Circulation
MARCH 3, 2024
Circulation, Volume 149, Issue 10 , Page 744-746, March 5, 2024.
Circulation
MARCH 3, 2024
Circulation, Volume 149, Issue 10 , Page 788-789, March 5, 2024.
Circulation
MARCH 3, 2024
Circulation, Volume 149, Issue 10 , Page 799-799, March 5, 2024.
Circulation
MARCH 3, 2024
Circulation, Volume 149, Issue 10 , Page 797-798, March 5, 2024.
Circulation
MARCH 3, 2024
Circulation, Volume 149, Issue 10 , Page 732-733, March 5, 2024.
Circulation
MARCH 3, 2024
Circulation, Volume 149, Issue 10 , Page 790-793, March 5, 2024.
Circulation
MARCH 3, 2024
Circulation, Volume 149, Issue 10 , Page 794-796, March 5, 2024.
Expert insights. Personalized for you.
99 
Let's personalize your content